| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3201129 | Journal of Allergy and Clinical Immunology | 2009 | 8 Pages |
Abstract
Studies are required to elucidate how asthma exposes older women to excess macrovascular risk and prospectively determine the short-acting β2-agonist-related risk in persons without existing CVD. CVD risk in relation to atopic status of asthma also requires further investigation.
Keywords
Computer-Assisted Telephone InterviewLTC4SABACHDSBRICSCATIFVCROSAdrenergic β-agonistsAsthmaLong-acting β2-agonistShort-acting β2-agonistObstructiveEpidemiologycoronary heart diseasecardiovascular diseaseCOPDChronic obstructive pulmonary diseaseLung diseasesCVDLABACardiovascular systembody mass indexBMIforced vital capacityLeukotriene C4odds ratioInhaled corticosteroidReactive oxygen species
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sarah L. BSc (Hons), Richard E. MBBS, MD, David H. PhD, Anne W. PhD, Robert J. MBBS, MD, North West Adelaide Cohort Health Study Team North West Adelaide Cohort Health Study Team,